A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease.
Open Access
- 1 July 1992
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 55 (7) , 630-631
- https://doi.org/10.1136/jnnp.55.7.630-a
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.The Journal of Pharmacology and Experimental Therapeutics, 2025
- Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.The Journal of Pharmacology and Experimental Therapeutics, 2025
- Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines.Molecular Pharmacology, 2025
- Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonistsNature, 1991
- NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted ratsAnnals of Neurology, 1990
- Excitatory amino acid antagonists and Parkinson's diseaseTrends in Neurosciences, 1990
- IFENPRODIL AND SL-82.0715 AS CEREBRAL ANTIISCHEMIC AGENTS .3. EVIDENCE FOR ANTAGONISTIC EFFECTS AT THE POLYAMINE MODULATORY SITE WITHIN THE N-METHYL-D-ASPARTATE RECEPTOR COMPLEX1990
- Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonismLife Sciences, 1990
- IFENPRODIL IS A NOVEL TYPE OF N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST - INTERACTION WITH POLYAMINES1989
- IFENPRODIL AND SL-82.0715 AS CEREBRAL ANTI-ISCHEMIC AGENTS .2. EVIDENCE FOR N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST PROPERTIES1988